Studies have demonstrated that suppression of the PI3k/AKT/mTOR pathway by an mTOR inhibitor may inhibit cancer cell invasion and migration and promote apoptosis in tumors, while PI3K signaling is known to contribute to the advancement of cancer [33,34,35,36]. Here, AKT1 is linked to cancer.